Financial expert warns: Dependence on third countries for drug production threatens the supply situation

Financial expert warns: Dependence on third countries for drug production threatens the supply situation

According to a report by Deutschlandfunk, the southern states of Bavaria, Baden-Württemberg, Rhineland-Palatinate and Hesse are calling for economic policy measures to reduce dependencies on third countries in the production of medicines. They would like to strengthen pharmaceutical production in Germany, as the supply situation could deteriorate further without additional measures.

It is undeniable that dependence on third countries for the production of medicines represents a major risk. Strengthening pharmaceutical production in Germany could increase security of supply and mitigate negative effects on the market. However, this requires extensive economic policy measures and investments. This could lead to higher costs in the short term, but improve health care delivery and health system resilience in the long term.

The discussion about reducing dependence on third countries in drug production could also lead to a realignment of global economic relations in the pharmaceutical industry. Investment and production in Germany may become more attractive while other countries reconsider their dependence on certain manufacturers and supplier countries.

Overall, this could lead to an improvement in security of supply and a broader range of medicines on the market. Strengthening pharmaceutical production in Germany could also create new jobs, which would have a positive impact on the region's economy.